CLPS Incorporation Appoints Ms. Sarah Wu as Non-Executive Director of QCC to Drive Strategic Growth in Credit Card Solutions
HONG KONG, Nov. 22, 2024 /PRNewswire/ — CLPS Incorporation (the “Company” or “CLPS”) (Nasdaq: CLPS), today announced the appointment... Read more.
Palo Alto Networks to Present at Upcoming Investor Event
SANTA CLARA, Calif., Nov. 22, 2024 /PRNewswire/ — Palo Alto Networks (NASDAQ: PANW), the global cybersecurity leader, announced today that members of its management... Read more.
Social Assurance Adds Threads to its Content & Compliance Management Software
LINCOLN, Neb., Nov. 22, 2024 /PRNewswire/ — Social Assurance–the leading marketing and compliance management platform for community banks, credit unions,... Read more.
MIT Sloan Professor Steven Eppinger Joins SurgiBox’s Board of Directors
CAMBRIDGE, Mass., Nov. 22, 2024 /PRNewswire/ — SurgiBox, a pioneer in ultra-portable, inflatable surgical environments designed to make safe surgery possible... Read more.
Anixa Biosciences Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset
SAN JOSE, Calif., Nov. 22, 2024 /PRNewswire/ — Anixa Biosciences, Inc. (“Anixa” or the “Company”) (NASDAQ: ANIX), a biotechnology company... Read more.
EQT Exeter To Acquire More Than One Million Square Feet of Class A Bulk Distribution Buildings in the Napa Valley Region of California
Bulk distribution buildings offer premier access to Northern California’s major metros and Western U.S., and are purpose-built to meet the needs of both logistics... Read more.
VANKYO Unveils the 2024 Holiday Gift Guide to Deliver Big Value at Black Friday
Perfect Holiday Gifts for Home Entertainment Lovers, Available at Best Buy, Walmart, and Target BELTSVILLE, Md., Nov. 22, 2024 /PRNewswire/ — This holiday... Read more.
Verra Mobility to Participate at the UBS Global Technology and AI Conference
MESA, Ariz., Nov. 22, 2024 /PRNewswire/ — Verra Mobility Corporation (NASDAQ: VRRM), a leading provider of smart mobility technology solutions, announced... Read more.
U.S. FDA Approves StemCyte Biologics License Application for REGENECYTE™ Cord Blood Cell Therapy Product
BALDWIN PARK, Calif., Nov. 22, 2024 /PRNewswire/ — StemCyte Inc., a wholly owned subsidiary of StemCyte International Ltd., announced today that the U.S. Food... Read more.
BioSurfaces Receives $2.06 Million Grant to Advance Development of Bio-Spun™ Cell Chamber Device
Funding Secured from the Bill & Melinda Gates Foundation Focuses on Developing Next Generation Device for Long-Term Therapy Delivery ASHLAND, Mass., Nov.... Read more.